These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 25162954)

  • 21. Editor's Choice - A Systematic Review and Meta-Analysis of the Efficacy and Safety of Anticoagulation in the Treatment of Venous Thromboembolism in Patients with Cancer.
    Kirkilesis GI; Kakkos SK; Tsolakis IA
    Eur J Vasc Endovasc Surg; 2019 May; 57(5):685-701. PubMed ID: 31097186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery.
    Rasmussen MS; Jørgensen LN; Wille-Jørgensen P
    Cochrane Database Syst Rev; 2009 Jan; (1):CD004318. PubMed ID: 19160234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anticoagulation for thrombosis prophylaxis in cancer patients with central venous catheters.
    Akl EA; Karmath G; Yosuico V; Kim SY; Barba M; Sperati F; Cook D; Schünemann HJ
    Cochrane Database Syst Rev; 2007 Jul; (3):CD006468. PubMed ID: 17636845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meta-analysis of heparin therapy for preventing venous thromboembolism in acute spinal cord injury.
    Liu Y; Xu H; Liu F; Lv Z; Kan S; Ning G; Feng S
    Int J Surg; 2017 Jul; 43():94-100. PubMed ID: 28579397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of Prophylaxis for Prevention of Venous Thromboembolism in Patients with Isolated Foot or Ankle Surgery: A Systematic Review and Meta-Analysis.
    Bikdeli B; Visvanathan R; Jimenez D; Monreal M; Goldhaber SZ; Bikdeli B
    Thromb Haemost; 2019 Oct; 119(10):1686-1694. PubMed ID: 31430799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of extended thromboprophylaxis for medically ill patients. A meta-analysis of randomised controlled trials.
    Dentali F; Mumoli N; Prisco D; Fontanella A; Di Minno MN
    Thromb Haemost; 2017 Feb; 117(3):606-617. PubMed ID: 28078350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effectiveness and safety of direct oral anticoagulants compared to conventional pharmacologic thromboprophylaxis in hip fracture patients: A systematic review and meta-analysis of randomized controlled trials.
    Abatzis-Papadopoulos M; Tigkiropoulos K; Nikas S; Papoutsis I; Kostopoulou O; Stavridis K; Karamanos D; Lazaridis I; Saratzis N
    Orthop Traumatol Surg Res; 2023 Apr; 109(2):103364. PubMed ID: 35817368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological venous thromboembolism prophylaxis in hospitalized medical patients: a meta-analysis of randomized controlled trials.
    Wein L; Wein S; Haas SJ; Shaw J; Krum H
    Arch Intern Med; 2007 Jul; 167(14):1476-86. PubMed ID: 17646601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thromboprophylaxis in nonsurgical patients.
    Streiff MB; Lau BD
    Hematology Am Soc Hematol Educ Program; 2012; 2012():631-7. PubMed ID: 23233645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Direct oral anticoagulants for thromboprophylaxis in ambulatory patients with cancer.
    Wang Y; Wang M; Ni Y; Liang Z
    Hematology; 2020 Dec; 25(1):63-70. PubMed ID: 31984870
    [No Abstract]   [Full Text] [Related]  

  • 31. Low molecular weight heparin in treating patients with lung cancer received chemotherapy: A meta-analysis.
    Liu ZL; Wang Q; Wang M; Wang B; Huang LN
    J Cancer Res Ther; 2018 Jun; 14(Supplement):S437-S443. PubMed ID: 29970703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct oral anticoagulant (DOAC) versus low-molecular-weight heparin (LMWH) for the treatment of cancer-associated thrombosis (which agent for which patient).
    Pernod G; Joly M; Sonnet B
    J Med Vasc; 2020 Nov; 45(6S):6S17-6S23. PubMed ID: 33276939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of aspirin versus low-molecular-weight heparin for venous thromboembolism prophylaxis after total knee arthroplasty: a meta-analysis of randomized controlled trials.
    Meng J; Liu W; Xiao Y; Tang H; Wu Y; Gao S
    Int J Surg; 2023 Nov; 109(11):3648-3655. PubMed ID: 37578443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of Venous Thromboembolism after Arthroscopic Knee Surgery in a Low-Risk Population with the Use of Aspirin. A Randomized Trial.
    Kaye ID; Patel DN; Strauss EJ; Alaia MJ; Garofolo G; Martinez A; Jazrawi LM
    Bull Hosp Jt Dis (2013); 2015 Dec; 73(4):243-8. PubMed ID: 26630467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct oral anticoagulant versus low-molecular-weight heparin for treatment of venous thromboembolism in cancer patients: An updated meta-analysis of randomized controlled trials.
    Haykal T; Zayed Y; Deliwala S; Kerbage J; Ponnapalli A; Malladi S; Goranta S; Samji V; Adam S
    Thromb Res; 2020 Oct; 194():57-65. PubMed ID: 32788122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized study on 1-week versus 4-week prophylaxis for venous thromboembolism after laparoscopic surgery for colorectal cancer.
    Vedovati MC; Becattini C; Rondelli F; Boncompagni M; Camporese G; Balzarotti R; Mariani E; Flamini O; Pucciarelli S; Donini A; Agnelli G
    Ann Surg; 2014 Apr; 259(4):665-9. PubMed ID: 24253138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is There a Role for Anti-factor Xa Activity Assay in Venous Thromboembolism Prophylaxis Management Among Orthopaedic Trauma Patients? Systematic Review and Meta-analysis.
    Tischler EH; Tsai SHL; Wolfert AJ; von Keudell A; Roudnitsky V; Gross J; Suneja N
    J Orthop Trauma; 2023 Sep; 37(9):e368-e376. PubMed ID: 37053117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aspirin versus low-molecular-weight heparin for thromboprophylaxis after orthopaedic surgery: a systematic review and meta-analysis.
    Wu H; Zhou L; Wang Q; Wang T; Liang S
    Blood Coagul Fibrinolysis; 2024 Jun; 35(4):187-195. PubMed ID: 38652521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The efficacy and safety of low-molecular-weight heparin use for cancer treatment: a meta-analysis.
    Che DH; Cao JY; Shang LH; Man YC; Yu Y
    Eur J Intern Med; 2013 Jul; 24(5):433-9. PubMed ID: 23385011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thromboprophylaxis with low molecular weight heparin versus unfractionated heparin in intensive care patients: a systematic review with meta-analysis and trial sequential analysis.
    Beitland S; Sandven I; Kjærvik LK; Sandset PM; Sunde K; Eken T
    Intensive Care Med; 2015 Jul; 41(7):1209-19. PubMed ID: 25971389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.